Auxilium Pharmaceuticals, and Glaxo Smith Kline have entered into an agreement to co-promote Testim (testosterone gel) testosterone replacement therapy product...
Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests (see section 4.4).
Allergan plc announced that the Company has received approval from the FDA to market Aczone (dapsone) Gel, 7.5%, a new...
Galderma announced that it has received a Positive Opinion from 16 concerned European regulatory agencies for the market approval of...
The FDA) has approved Bio-T-Gel, which is licensed by BioSante to Teva Pharmaceuticals USA, Inc. Bio-T-Gel is a testosterone gel...
The injectable ACTH gel medication Cortrophin Gel (repository corticotropin injection), first introduced in the U.S. in the 1950s, will now be relaunched by ANI Pharmaceuticals as a treatment for acute flare-ups in multiple sclerosis (MS) and other autoimmune conditions, following its approval by the FDA.
Sol-Gel Technologies, Ltd. announced an update regarding the FDA approval process for Epsolay (benzoyl peroxide) 5% topical cream for the treatment of Inflammatory lesions of rosacea in adults. In September of 2020, Sol-Gel was informed by the FDA that the PDUFA goal date for Epsolay is April 26, 2021.
Endo International plc has announced that it has introduced the first and only generic 2% topical testosterone gel, an authorized...
Valeant Pharmaceuticals International, Inc. has announced that it has received approval from the FDA for Onexton Gel (clindamycin phosphate and...